Novan Inc. | Mutual Funds
Mutual Funds that own Novan Inc.
Vanguard Total Stock Market Index Fund
590,876
2.27%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
255,311
0.98%
0
0%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
197,064
0.76%
0
0.02%
06/30/2018
Franklin Biotechnology Discovery Fund
120,969
0.47%
0
0.02%
03/31/2018
iShares Micro Cap ETF
47,349
0.18%
0
0.01%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
45,951
0.18%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
36,199
0.14%
0
0%
07/31/2018
Vanguard Balanced Index Fund
25,741
0.1%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
22,688
0.09%
0
0.02%
12/31/2017
Fidelity Spartan Total Market Index Fund
7,147
0.03%
0
0%
07/31/2018
| Address |
4105 Hopson Road
Morrisville North Carolina 27560
United States
|
|
Employees
|
- |
| Website |
http://www.novan.com |
| Updated |
07/08/2019 |
| Novan, Inc. is a biotechnology company which uses nitric oxide-based technology to develop product candidates. It focuses on nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC. |
